Research Projects
Type one diabetes (T1D) has reached epidemic proportions and people living with the disease are dependent on insulin therapy to help keep their blood...
Supervisor: Prof Christoph Hagemeyer
This project is based on the single-chain antibody (scFv) technology, an emerging class of biotechnologically produced therapeutics. ScFvs are...
Supervisor: Prof Christoph Hagemeyer
This project aims to develop nanoparticle contrast agents for magnetic resonance imaging (MRI) that selectively target molecular markers of...
Supervisor: Prof Christoph Hagemeyer
Single-chain antibodies against epitopes associated with vascular dysfunction / injury provide a unique tool for specific targeting of exosomes in...
Supervisor: Prof Christoph Hagemeyer